Parallel Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Parallel Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-296	Closed	-$1.66K	–	3500
2023 Q2	$1.66K	Hold	296	–	–	﹤0.01%	2804
2023 Q1	$1.78K	Hold	296	–	–	﹤0.01%	2810
2022 Q4	$1.69K	Hold	296	–	–	﹤0.01%	2749
2022 Q3	$2K	Hold	296	–	–	﹤0.01%	2795
2022 Q2	$1K	Buy	+296	New	+$1.1K	﹤0.01%	2899

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Parallel Advisors's OMGA Position: Q3 2023 in Review

Parallel Advisors sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2023, closing a stake of 296 shares — an estimated $1.66K sold.

Parallel Advisors first reported a position in OMGA in Q2 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 58 funds tracked by Wall St. Rank hold OMGA as of Q3 2023.

Parallel Advisors reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Parallel Advisors sold 296 Omega Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.66K.
Parallel Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Parallel Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2022.
58 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.